Supplementary Materials For

Total Page:16

File Type:pdf, Size:1020Kb

Supplementary Materials For Supplementary Materials for A high coverage genome sequence from an archaic Denisovan individual Matthias Meyer, Martin Kircher, Marie-Theres Gansauge, Heng Li, Fernando Racimo, Swapan Mallick, Joshua G. Schraiber, Flora Jay, Kay Prüfer, Cesare de Filippo, Peter H. Sudmant, Can Alkan, Qiaomei Fu, Ron Do, Nadin Rohland, Arti Tandon, Michael Siebauer, Richard E. Green, Katarzyna Bryc, Adrian W. Briggs, Udo Stenzel, Jesse Dabney, Jay Shendure, Jacob Kitzman, Michael F. Hammer, Michael V. Shunkov, Anatoli P. Derevianko, Nick Patterson, Aida M. Andrés, Evan E. Eichler, Montgomery Slatkin, David Reich, Janet Kelso, Svante Pääbo correspondence to: [email protected] This PDF file includes: Materials and Methods Figs. S1 to S38 Tables S1 to S43, S45 to S47, S51 to S53, S56 to S58 Other Supplementary Materials for this manuscript includes the following: 1224344s2.xls (Tables S44, S48, S49, S50, S54 and S55) 1 Materials and methods Table of Contents Note 1: Sampling and extraction of side fractions .......................................................................... 3 Note 2: Library preparation and sequencing ................................................................................... 4 Note 3: Comparison of the single-stranded and double-stranded library preparation methods ..... 9 Note 4: Processing and mapping raw sequence data from Denisova ........................................... 12 Note 5: Sequencing and processing of 11 present-day human genomes ...................................... 14 Note 6: Extended Variant Call Format files ................................................................................. 16 Note 7: Estimates of present-day human contamination in Denisova .......................................... 21 Note 8: Assessing genome sequence quality ................................................................................ 25 Note 9: Estimates of sequence divergence of Denisovans and present-day humans .................... 27 Note 10: Date of population divergence of modern humans from Denisovans and Neandertals . 32 Note 11: D-statistics and interbreeding between archaic and modern humans ............................ 36 Note 12: Relationship between Denisova and 11 present-day human genomes .......................... 47 Note 13: Segmental duplication and copy number variation analysis .......................................... 49 Note 14: Chromosome Two Fusion Site ....................................................................................... 53 Note 15: Estimating heterozygosity in Denisova and 11 present-day human genomes ............... 55 Note 16: The Denisovan genome lacks a signal of recent inbreeding .......................................... 58 Note 17: Inferred population size changes in the history of Denisovans ..................................... 59 Note 18: Less effective selection in Denisovans than modern humans due to a smaller population size ................................................................................................................................................ 61 Note 19: A complete catalog of features unique to the human genome ....................................... 64 Note 20: Catalog of features unique to the Denisovan genome .................................................... 73 Supplementary Figures ................................................................................................................. 75 Supplementary Tables ................................................................................................................. 101 2 Note 1: Sampling and extraction of side fractions Marie-Theres Gansauge, Qiaomei Fu and Matthias Meyer* * To whom correspondence should be addressed ([email protected]) In 2010, two extracts (E236 and E245), each with a volume of 100 µl, were prepared from 40mg of the Denisovan phalanx (2) (see Figure S1 for an overview of bone material usage). For initial screening of the bone, sequencing libraries were prepared without prior excision of deoxyuracils from the template strands. When analysis of captured mtDNA fragments revealed that the sample came from a previously unknown hominin (4) and that the DNA fragments contained patterns of nucleotide misincorporations typical of ancient DNA (9), fractions of the extracts were treated with uracil-DNA-glycosylase (UDG) and endonuclease VIII (29) to produce two libraries (SL3003 and SL3004) that were used to generate the nuclear DNA sequences that were analyzed and published earlier (2). We routinely freeze all relevant side fractions arising during DNA extraction. The silica-based DNA extraction process used (30) involves three steps: (i) sample lysis in an EDTA/proteinase K buffer, (ii) DNA binding to a silica suspension in the presence of chaotropic salts (iii) ethanol wash and elution in low-salt buffer. From each extraction, the following side fractions are kept: (i) any undissolved bone powder; (ii) binding supernatant; (iii) the silica pellet. The bone powder from the phalanx was completely dissolved. We used the binding supernatant and the silica pellet of E245 in an attempt to recover additional molecules. In a falcon tube, 30 µl of new silica suspension were added to 5 ml of ‘left-over’ binding supernatant. After rotating for three hours in the dark, the silica was pelleted by centrifugation and washed twice in washing buffer. DNA was eluted in 28 µl TE buffer and transferred to the old silica pellet for re-elution, thereby combining the molecules recovered from both side fractions (ii and iii) of E245. 3 Note 2: Library preparation and sequencing Marie-Theres Gansauge, Qiaomei Fu and Matthias Meyer* * To whom correspondence should be addressed ([email protected]) Method summary A schematic overview of the single-stranded library preparation method as well as the two double-stranded methods previously used for library preparation from ancient DNA (31, 32) is provided in Figure S2. In more detail, the single-stranded method involves the following steps: (i) Input DNA is treated with a mixture of uracil-DNA-glycosylase (UDG) and endonuclease VIII, which removes uracils from DNA strands and converts resulting abasic sites into single-nucleotide gaps. This treatment is optional. (ii) To this reaction, a heat-labile phosphatase is added, which removes both 5’- and 3’- phosphates from DNA ends if present. (iii) The double-stranded molecules are heat-denatured and again treated with phosphatase to complete dephosphorylation. (iv) After heat-inactivation of the phosphatase, adaptor oligonucleotides of ten bases, which carry 5’-phosphates and 3’-biotin-linker arms, are ligated in the presence of polyethylene glycol (PEG) to the 3’-ends of the input molecules using CircLigase IITM, an enzyme that preferentially circularizes single-stranded DNA (33), but when presented with donor and acceptor molecules with only one ligatable end, efficiently achieves end-to-end ligation (34). (v) Ligation products as well as excess adaptors are subsequently bound to streptavidin- coated magnetic beads. (vi) A 5’-tailed primer, which carries a priming site for later amplification, is hybridized to the adaptor oligonucleotide, and the original template strand is copied using Bst polymerase (large fragment). (vii) T4 DNA polymerase is used to remove 3’-overhangs generated during the primer extension reaction. (viii) T4 DNA ligase is used to ligate the 5’-phosphorylated end of a double stranded adaptor to the 3’-end of the newly copied strand. The 3’-end of the adaptor carries a dideoxy modification to prevent adaptor self-ligation. Between all enzymatic reactions, beads are intensely washed, also at elevated temperature, to remove extension primers hybridized to excess adaptor oligonucleotides. 4 (ix) Finally, the original template molecules and the library molecules, i.e. copies with short adaptor sequences attached to each end, are released by heat-destruction of the beads. Libraries were prepared from extracts E236 and E245 as well as from the molecules recovered from the side fractions of extraction E245 using the single-stranded method (Table S1). In addition, water controls were carried through the library preparation process. The number of molecules in each library was estimated by qPCR (35, 36). According to these estimates, the sample extracts produced at least one order of magnitude more molecules than the water controls, indicating that less than 10% of library molecules are derived from artifacts. Full-length adaptor sequences, carrying sample-specific sequence tags (indexes), were then added to both ends of the library molecules by amplification with 5’-tailed primers (11). For a more efficient use of sequencing capacity, these amplified libraries were separated on polyacrylamide gels, and the fractions of library molecules with inserts larger than ~40 bp were excised. Sequence data was produced from amplified libraries both with and without size-fractionation, using a protocol for double-index sequencing described elsewhere (35). A special sequencing primer was used for the first read, because the P5 adaptor sequence was truncated by five bases compared to the design described previously (11) to avoid interactions between the highly self-complementary P5 and P7 adaptors during single-strand library preparation. In addition to sequencing the libraries prepared with the new single-stranded method, deeper sequencing was performed for libraries prepared in the previous study with the double-stranded method (SL3003 and SL3004) (2). Method details Sequences
Recommended publications
  • Biomarker Discovery for Chronic Liver Diseases by Multi-Omics
    www.nature.com/scientificreports OPEN Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case study Daniel Veyel1, Kathrin Wenger1, Andre Broermann2, Tom Bretschneider1, Andreas H. Luippold1, Bartlomiej Krawczyk1, Wolfgang Rist 1* & Eric Simon3* Nonalcoholic steatohepatitis (NASH) is a major cause of liver fbrosis with increasing prevalence worldwide. Currently there are no approved drugs available. The development of new therapies is difcult as diagnosis and staging requires biopsies. Consequently, predictive plasma biomarkers would be useful for drug development. Here we present a multi-omics approach to characterize the molecular pathophysiology and to identify new plasma biomarkers in a choline-defcient L-amino acid-defned diet rat NASH model. We analyzed liver samples by RNA-Seq and proteomics, revealing disease relevant signatures and a high correlation between mRNA and protein changes. Comparison to human data showed an overlap of infammatory, metabolic, and developmental pathways. Using proteomics analysis of plasma we identifed mainly secreted proteins that correlate with liver RNA and protein levels. We developed a multi-dimensional attribute ranking approach integrating multi-omics data with liver histology and prior knowledge uncovering known human markers, but also novel candidates. Using regression analysis, we show that the top-ranked markers were highly predictive for fbrosis in our model and hence can serve as preclinical plasma biomarkers. Our approach presented here illustrates the power of multi-omics analyses combined with plasma proteomics and is readily applicable to human biomarker discovery. Nonalcoholic fatty liver disease (NAFLD) is the major liver disease in western countries and is ofen associated with obesity, metabolic syndrome, or type 2 diabetes.
    [Show full text]
  • Mitoxplorer, a Visual Data Mining Platform To
    mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dynamics and mutations Annie Yim, Prasanna Koti, Adrien Bonnard, Fabio Marchiano, Milena Dürrbaum, Cecilia Garcia-Perez, José Villaveces, Salma Gamal, Giovanni Cardone, Fabiana Perocchi, et al. To cite this version: Annie Yim, Prasanna Koti, Adrien Bonnard, Fabio Marchiano, Milena Dürrbaum, et al.. mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dy- namics and mutations. Nucleic Acids Research, Oxford University Press, 2020, 10.1093/nar/gkz1128. hal-02394433 HAL Id: hal-02394433 https://hal-amu.archives-ouvertes.fr/hal-02394433 Submitted on 4 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Nucleic Acids Research, 2019 1 doi: 10.1093/nar/gkz1128 Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gkz1128/5651332 by Bibliothèque de l'université la Méditerranée user on 04 December 2019 mitoXplorer, a visual data mining platform to systematically analyze and visualize mitochondrial expression dynamics and mutations Annie Yim1,†, Prasanna Koti1,†, Adrien Bonnard2, Fabio Marchiano3, Milena Durrbaum¨ 1, Cecilia Garcia-Perez4, Jose Villaveces1, Salma Gamal1, Giovanni Cardone1, Fabiana Perocchi4, Zuzana Storchova1,5 and Bianca H.
    [Show full text]
  • A Bioinformatics Tool for Prioritizing Biological Leads from ‘Omics Data Using Literature Retrieval and Data Mining
    International Journal of Molecular Sciences Article OmixLitMiner: A Bioinformatics Tool for Prioritizing Biological Leads from ‘Omics Data Using Literature Retrieval and Data Mining Pascal Steffen 1,2,3 , Jemma Wu 2, Shubhang Hariharan 1, Hannah Voss 3, Vijay Raghunath 4, Mark P. Molloy 1,2,* and Hartmut Schlüter 3,* 1 Bowel Cancer and Biomarker Research, Kolling Institute, The University of Sydney, Sydney 2065, Australia; pascal.steff[email protected] (P.S.); [email protected] (S.H.) 2 Department of Molecular Sciences, Macquarie University, Sydney 2109, Australia; [email protected] 3 Mass Spectrometric Proteomics Group, Department of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg 20246, Germany; [email protected] 4 Sydney Informatics Hub, The University of Sydney, Sydney 2008, Australia; [email protected] * Correspondence: [email protected] (M.P.M.); [email protected] (H.S.) Received: 7 November 2019; Accepted: 13 February 2020; Published: 19 February 2020 Abstract: Proteomics and genomics discovery experiments generate increasingly large result tables, necessitating more researcher time to convert the biological data into new knowledge. Literature review is an important step in this process and can be tedious for large scale experiments. An informed and strategic decision about which biomolecule targets should be pursued for follow-up experiments thus remains a considerable challenge. To streamline and formalise this process of literature retrieval and analysis of discovery based ‘omics data and as a decision-facilitating support tool for follow-up experiments we present OmixLitMiner, a package written in the computational language R. The tool automates the retrieval of literature from PubMed based on UniProt protein identifiers, gene names and their synonyms, combined with user defined contextual keyword search (i.e., gene ontology based).
    [Show full text]
  • Supplementary Table 3: Genes Only Influenced By
    Supplementary Table 3: Genes only influenced by X10 Illumina ID Gene ID Entrez Gene Name Fold change compared to vehicle 1810058M03RIK -1.104 2210008F06RIK 1.090 2310005E10RIK -1.175 2610016F04RIK 1.081 2610029K11RIK 1.130 381484 Gm5150 predicted gene 5150 -1.230 4833425P12RIK -1.127 4933412E12RIK -1.333 6030458P06RIK -1.131 6430550H21RIK 1.073 6530401D06RIK 1.229 9030607L17RIK -1.122 A330043C08RIK 1.113 A330043L12 1.054 A530092L01RIK -1.069 A630054D14 1.072 A630097D09RIK -1.102 AA409316 FAM83H family with sequence similarity 83, member H 1.142 AAAS AAAS achalasia, adrenocortical insufficiency, alacrimia 1.144 ACADL ACADL acyl-CoA dehydrogenase, long chain -1.135 ACOT1 ACOT1 acyl-CoA thioesterase 1 -1.191 ADAMTSL5 ADAMTSL5 ADAMTS-like 5 1.210 AFG3L2 AFG3L2 AFG3 ATPase family gene 3-like 2 (S. cerevisiae) 1.212 AI256775 RFESD Rieske (Fe-S) domain containing 1.134 Lipo1 (includes AI747699 others) lipase, member O2 -1.083 AKAP8L AKAP8L A kinase (PRKA) anchor protein 8-like -1.263 AKR7A5 -1.225 AMBP AMBP alpha-1-microglobulin/bikunin precursor 1.074 ANAPC2 ANAPC2 anaphase promoting complex subunit 2 -1.134 ANKRD1 ANKRD1 ankyrin repeat domain 1 (cardiac muscle) 1.314 APOA1 APOA1 apolipoprotein A-I -1.086 ARHGAP26 ARHGAP26 Rho GTPase activating protein 26 -1.083 ARL5A ARL5A ADP-ribosylation factor-like 5A -1.212 ARMC3 ARMC3 armadillo repeat containing 3 -1.077 ARPC5 ARPC5 actin related protein 2/3 complex, subunit 5, 16kDa -1.190 activating transcription factor 4 (tax-responsive enhancer element ATF4 ATF4 B67) 1.481 AU014645 NCBP1 nuclear cap
    [Show full text]
  • Nuclear PTEN Safeguards Pre-Mrna Splicing to Link Golgi Apparatus for Its Tumor Suppressive Role
    ARTICLE DOI: 10.1038/s41467-018-04760-1 OPEN Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role Shao-Ming Shen1, Yan Ji2, Cheng Zhang1, Shuang-Shu Dong2, Shuo Yang1, Zhong Xiong1, Meng-Kai Ge1, Yun Yu1, Li Xia1, Meng Guo1, Jin-Ke Cheng3, Jun-Ling Liu1,3, Jian-Xiu Yu1,3 & Guo-Qiang Chen1 Dysregulation of pre-mRNA alternative splicing (AS) is closely associated with cancers. However, the relationships between the AS and classic oncogenes/tumor suppressors are 1234567890():,; largely unknown. Here we show that the deletion of tumor suppressor PTEN alters pre-mRNA splicing in a phosphatase-independent manner, and identify 262 PTEN-regulated AS events in 293T cells by RNA sequencing, which are associated with significant worse outcome of cancer patients. Based on these findings, we report that nuclear PTEN interacts with the splicing machinery, spliceosome, to regulate its assembly and pre-mRNA splicing. We also identify a new exon 2b in GOLGA2 transcript and the exon exclusion contributes to PTEN knockdown-induced tumorigenesis by promoting dramatic Golgi extension and secretion, and PTEN depletion significantly sensitizes cancer cells to secretion inhibitors brefeldin A and golgicide A. Our results suggest that Golgi secretion inhibitors alone or in combination with PI3K/Akt kinase inhibitors may be therapeutically useful for PTEN-deficient cancers. 1 Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai 200025, China. 2 Institute of Health Sciences, Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences and SJTU-SM, Shanghai 200025, China.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • In This Table Protein Name, Uniprot Code, Gene Name P-Value
    Supplementary Table S1: In this table protein name, uniprot code, gene name p-value and Fold change (FC) for each comparison are shown, for 299 of the 301 significantly regulated proteins found in both comparisons (p-value<0.01, fold change (FC) >+/-0.37) ALS versus control and FTLD-U versus control. Two uncharacterized proteins have been excluded from this list Protein name Uniprot Gene name p value FC FTLD-U p value FC ALS FTLD-U ALS Cytochrome b-c1 complex P14927 UQCRB 1.534E-03 -1.591E+00 6.005E-04 -1.639E+00 subunit 7 NADH dehydrogenase O95182 NDUFA7 4.127E-04 -9.471E-01 3.467E-05 -1.643E+00 [ubiquinone] 1 alpha subcomplex subunit 7 NADH dehydrogenase O43678 NDUFA2 3.230E-04 -9.145E-01 2.113E-04 -1.450E+00 [ubiquinone] 1 alpha subcomplex subunit 2 NADH dehydrogenase O43920 NDUFS5 1.769E-04 -8.829E-01 3.235E-05 -1.007E+00 [ubiquinone] iron-sulfur protein 5 ARF GTPase-activating A0A0C4DGN6 GIT1 1.306E-03 -8.810E-01 1.115E-03 -7.228E-01 protein GIT1 Methylglutaconyl-CoA Q13825 AUH 6.097E-04 -7.666E-01 5.619E-06 -1.178E+00 hydratase, mitochondrial ADP/ATP translocase 1 P12235 SLC25A4 6.068E-03 -6.095E-01 3.595E-04 -1.011E+00 MIC J3QTA6 CHCHD6 1.090E-04 -5.913E-01 2.124E-03 -5.948E-01 MIC J3QTA6 CHCHD6 1.090E-04 -5.913E-01 2.124E-03 -5.948E-01 Protein kinase C and casein Q9BY11 PACSIN1 3.837E-03 -5.863E-01 3.680E-06 -1.824E+00 kinase substrate in neurons protein 1 Tubulin polymerization- O94811 TPPP 6.466E-03 -5.755E-01 6.943E-06 -1.169E+00 promoting protein MIC C9JRZ6 CHCHD3 2.912E-02 -6.187E-01 2.195E-03 -9.781E-01 Mitochondrial 2-
    [Show full text]
  • Proteomic Characterization of Transcription and Splicing Factors Associated with a Metastatic Phenotype in Colorectal Cancer
    Proteomic characterization of transcription and splicing factors associated with a metastatic phenotype in colorectal cancer Sofía Torres1+, Irene García-Palmero1+, Consuelo Marín-Vicente1,2, Rubén A. Bartolomé1, Eva Calviño1, María Jesús Fernández-Aceñero3 and J. Ignacio Casal1* +. Equal authorship 1. Functional proteomics. Centro de Investigaciones Biológicas (CIB-CSIC). Ramiro de Maeztu 9. Madrid. Spain. 2. Proteomic facilities. CIB-CSIC. Madrid. Spain 3. Department of Pathology. Hospital Clínico. Madrid. Spain Running title: Transcription factors in metastatic colorectal cancer Keywords: SRSF3, transcription factors, splicing factors, metastasis, colorectal cancer *. Corresponding author J. Ignacio Casal Department of Cellular and Molecular Medicine Centro de Investigaciones Biológicas (CIB-CSIC) Ramiro de Maeztu, 9 28040 Madrid, Spain Phone: +34 918373112 Fax: +34 91 5360432 Email: [email protected] 1 ABSTRACT We investigated new transcription and splicing factors associated with the metastatic phenotype in colorectal cancer. A concatenated tandem array of consensus transcription factors (TFs)-response elements was used to pull down nuclear extracts in two different pairs of colorectal cancer cells, KM12SM/KM12C and SW620/480, genetically-related but differing in metastatic ability. Proteins were analyzed by label-free LC-MS and quantified with MaxLFQ. We found 240 proteins showing a significant dysregulation in highly- metastatic KM12SM cells relative to non-metastatic KM12C cells and 257 proteins in metastatic SW620 versus SW480. In both cell lines there were similar alterations in genuine TFs and components of the splicing machinery like UPF1, TCF7L2/TCF-4, YBX1 or SRSF3. However, a significant number of alterations were cell-line specific. Functional silencing of MAFG, TFE3, TCF7L2/TCF-4 and SRSF3 in KM12 cells caused alterations in adhesion, survival, proliferation, migration and liver homing, supporting their role in metastasis.
    [Show full text]
  • HMMR Acts in the PLK1-Dependent Spindle Positioning Pathway And
    RESEARCH ARTICLE HMMR acts in the PLK1-dependent spindle positioning pathway and supports neural development Marisa Connell1†, Helen Chen1†, Jihong Jiang1, Chia-Wei Kuan2, Abbas Fotovati1, Tony LH Chu1, Zhengcheng He1, Tess C Lengyell3, Huaibiao Li4, Torsten Kroll4, Amanda M Li1, Daniel Goldowitz3,5, Lucien Frappart4, Aspasia Ploubidou4, Millan S Patel5, Linda M Pilarski6, Elizabeth M Simpson3,5, Philipp F Lange2,7, Douglas W Allan8, Christopher A Maxwell1,7* 1Department of Paediatrics, University of British Columbia, Vancouver, Canada; 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; 3Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada; 4Leibniz Institute on Aging—Fritz Lipmann Institute, Beutenbergstrasse, Germany; 5Department of Medical Genetics, University of British Columbia, Vancouver, Canada; 6Cross Cancer Institute, Department of Oncology, University of Alberta, Edmonton, Canada; 7Michael Cuccione Childhood Cancer Research Program, BC Children’s Hospital, Vancouver, Canada; 8Department of Cellular and Physiological Sciences, Life Sciences Centre, University of British Columbia, Vancouver, Canada Abstract Oriented cell division is one mechanism progenitor cells use during development and to maintain tissue homeostasis. Common to most cell types is the asymmetric establishment and regulation of cortical NuMA-dynein complexes that position the mitotic spindle. Here, we discover *For correspondence: cmaxwell@ bcchr.ubc.ca that HMMR acts at centrosomes in a PLK1-dependent pathway that locates active Ran and modulates the cortical localization of NuMA-dynein complexes to correct mispositioned spindles. † These authors contributed This pathway was discovered through the creation and analysis of Hmmr-knockout mice, which equally to this work suffer neonatal lethality with defective neural development and pleiotropic phenotypes in multiple Competing interests: The tissues.
    [Show full text]
  • Single Cell Derived Clonal Analysis of Human Glioblastoma Links
    SUPPLEMENTARY INFORMATION: Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity ! Mona Meyer*, Jüri Reimand*, Xiaoyang Lan, Renee Head, Xueming Zhu, Michelle Kushida, Jane Bayani, Jessica C. Pressey, Anath Lionel, Ian D. Clarke, Michael Cusimano, Jeremy Squire, Stephen Scherer, Mark Bernstein, Melanie A. Woodin, Gary D. Bader**, and Peter B. Dirks**! ! * These authors contributed equally to this work.! ** Correspondence: [email protected] or [email protected]! ! Supplementary information - Meyer, Reimand et al. Supplementary methods" 4" Patient samples and fluorescence activated cell sorting (FACS)! 4! Differentiation! 4! Immunocytochemistry and EdU Imaging! 4! Proliferation! 5! Western blotting ! 5! Temozolomide treatment! 5! NCI drug library screen! 6! Orthotopic injections! 6! Immunohistochemistry on tumor sections! 6! Promoter methylation of MGMT! 6! Fluorescence in situ Hybridization (FISH)! 7! SNP6 microarray analysis and genome segmentation! 7! Calling copy number alterations! 8! Mapping altered genome segments to genes! 8! Recurrently altered genes with clonal variability! 9! Global analyses of copy number alterations! 9! Phylogenetic analysis of copy number alterations! 10! Microarray analysis! 10! Gene expression differences of TMZ resistant and sensitive clones of GBM-482! 10! Reverse transcription-PCR analyses! 11! Tumor subtype analysis of TMZ-sensitive and resistant clones! 11! Pathway analysis of gene expression in the TMZ-sensitive clone of GBM-482! 11! Supplementary figures and tables" 13" "2 Supplementary information - Meyer, Reimand et al. Table S1: Individual clones from all patient tumors are tumorigenic. ! 14! Fig. S1: clonal tumorigenicity.! 15! Fig. S2: clonal heterogeneity of EGFR and PTEN expression.! 20! Fig. S3: clonal heterogeneity of proliferation.! 21! Fig.
    [Show full text]
  • Breeding Against Infectious Diseases in Animals
    Breeding against infectious diseases in animals Hamed Rashidi Thesis committee Promotor Prof. Dr J.A.M. van Arendonk Professor of Animal Breeding and Genomics Centre Wageningen University, The Netherlands Co-promotors Dr H.A. Mulder Assistant Professor, Animal Breeding and Genomics Centre Wageningen University, The Netherlands Dr P.K. Mathur Senior Geneticist, Topigs Norsvin Research Center The Netherlands Other members (assessment committee) Prof. Dr M.C.M. de Jong, Wageningen University, The Netherlands Prof. Dr J.A. Stegeman, Utrecht University, The Netherlands Prof. Dr J.K. Lunney, United States Department of Agriculture, USA Dr B. Nielsen, Pig Research Center, Denmark This research was conducted under the auspices of the Graduate School of Wageningen Institute of Animal Sciences (WIAS). Breeding against infectious diseases in animals Hamed Rashidi Thesis submitted in fulfillment of the requirements for the degree of doctor at Wageningen University by the authority of the Rector Magnificus Prof. Dr A.P.J. Mol, in the presence of the Thesis Committee appointed by the Acadamic Board to be defended in public on Friday March 18, 2016 at 16.00 p.m. in the Aula Rashidi, H. Breeding against infectious diseases in animals, 182 Pages. PhD thesis, Wageningen University, Wageningen, NL (2016) With references, with summary in English ISBN 978-94-6257-645-2 Abstract Infectious diseases in farm animals are of major concern because of welfare, production costs, and public health. Control strategies, however, are not always successful. Selective breeding for the animals that can defend against infections, therefore, could be an option. Defensive ability of animals against infections consists of resistance (ability to control pathogen burden) and tolerance (ability to maintain performance when pathogen burden increases).
    [Show full text]
  • Thesis Front Matter
    UNIVERSITY OF CALGARY Identification and Characterization of Murine Se70-2 by Stephanie E. Minnema A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY CALGARY, ALBERTA OCTOBER, 2006 © Stephanie E. Minnema 2006 Library and Archives Bibliothèque et Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l’édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A 0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 978-0-494-26242-9 Our file Notre référence ISBN: 978-0-494-26242-9 NOTICE: AVIS: The author has granted a non- L’auteur a accordé une licence non exclusive exclusive license allowing Library and permettant à la Bibliothèque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l’Internet, prêter, telecommunication or on the Internet, distribuer et vendre des thèses partout dans le loan, distribute and sell theses monde, à des fins commerciales ou autres, sur worldwide, for commercial or non- support microforme, papier, électronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L’auteur conserve la propriété du droit d’auteur ownership and moral rights in this et des droits moraux qui protège cette thèse. Ni thesis. Neither the thesis nor la thèse ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent être imprimés ou autrement printed or otherwise reproduced reproduits sans son autorisation.
    [Show full text]